Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 26, 2020; 8(22): 5657-5662
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5657
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5657
Figure 1 Clinical course with laboratory data during azacitidine therapy.
Red triangle (2 units): RBC: Red blood cell transfusions; ROS: Reactive oxygen species; AZA: Azacitidine, WT1: Wilms’ tumor 1; d-ROM: Derivatives of reactive oxygen metabolite; FER: Ferritin; Normal ranges: Serum d-ROM; < 300 Carratelli units; Ferritin: 18.6–261 ng/dL.
- Citation: Hasunuma H, Shimizu N, Yokota H, Tatsuno I. Azacitidine decreases reactive oxygen species production in peripheral white blood cells: A case report. World J Clin Cases 2020; 8(22): 5657-5662
- URL: https://www.wjgnet.com/2307-8960/full/v8/i22/5657.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i22.5657